Healthcare Sector Stocks
The Healthcare sector has a total of 1048 stocks, with a combined market cap of $9.86 trillion, total revenue of $4.74 trillion and a weighted average PE ratio of 46.26.
Market Cap
9.86T
Revenue
4.74T
Profits
213.19B
PE Ratio
46.26
Profit Margin
4.50%
Dividend Yield
0.38%
1047 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.26T | -1.13% | 1,960,514 | 86.46B |
| 2 | JNJ | Johnson & Johnson | 670.87B | -1.37% | 4,375,685 | 99.34B |
| 3 | ABBV | AbbVie Inc. | 517.40B | -0.62% | 3,694,960 | 66.01B |
| 4 | MRK | Merck & Co., Inc. | 353.12B | -0.84% | 5,422,111 | 67.38B |
| 5 | UNH | UnitedHealth Group Incorporated | 349.03B | -5.46% | 7,915,459 | 450.06B |
| 6 | NVS | Novartis AG | 298.09B | -0.69% | 1,463,328 | 57.36B |
| 7 | AZN | AstraZeneca PLC | 284.31B | -0.97% | 2,359,712 | 62.38B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 254.35B | -0.70% | 1,570,620 | 47.35B |
| 9 | AMGN | Amgen Inc. | 247.64B | -0.97% | 2,030,538 | 38.90B |
| 10 | GILD | Gilead Sciences, Inc. | 211.17B | 1.59% | 6,137,770 | 30.99B |
| 11 | ABT | Abbott Laboratories | 181.32B | -2.57% | 5,758,160 | 48.23B |
| 12 | NVO | Novo Nordisk A/S | 181.24B | -2.15% | 17,068,666 | 50.70B |
| 13 | PFE | Pfizer Inc. | 162.22B | -1.39% | 24,840,427 | 63.62B |
| 14 | DHR | Danaher Corporation | 158.66B | -1.91% | 3,555,472 | 25.61B |
| 15 | ISRG | Intuitive Surgical, Inc. | 149.14B | -1.72% | 2,441,787 | 11.58B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 135.40B | -0.70% | 1,315,378 | 12.95B |
| 17 | MCK | McKesson Corporation | 126.02B | -1.22% | 713,649 | 418.79B |
| 18 | BMY | Bristol-Myers Squibb Company | 125.44B | -2.49% | 14,393,294 | 50.03B |
| 19 | MDT | Medtronic plc | 125.24B | -0.55% | 5,255,359 | 37.54B |
| 20 | SYK | Stryker Corporation | 120.86B | 2.17% | 4,526,978 | 26.30B |
| 21 | SNY | Sanofi | 112.24B | -1.75% | 1,764,538 | 57.89B |
| 22 | CVS | CVS Health Corporation | 109.78B | -3.15% | 13,518,842 | 418.16B |
| 23 | HCA | HCA Healthcare, Inc. | 104.62B | -2.14% | 1,237,640 | 78.70B |
| 24 | GSK | GSK plc | 99.67B | -2.30% | 2,898,153 | 44.53B |
| 25 | REGN | Regeneron Pharmaceuticals, Inc. | 96.12B | 0.58% | 893,844 | 16.90B |
| 26 | ELV | Elevance Health, Inc. | 93.78B | -2.74% | 1,174,736 | 201.83B |
| 27 | MRNA | Moderna, Inc. | 83.63B | -3.99% | 8,164,387 | 2.53B |
| 28 | CI | The Cigna Group | 77.46B | -2.07% | 1,526,450 | 286.32B |
| 29 | TAK | Takeda Pharmaceutical Company Limited | 69.70B | 0.28% | 3,095,436 | 29.86B |
| 30 | COR | Cencora, Inc. | 66.85B | -1.86% | 1,250,535 | 337.40B |
| 31 | CAH | Cardinal Health, Inc. | 64.54B | -1.63% | 1,802,490 | 257.75B |
| 32 | BSX | Boston Scientific Corporation | 62.37B | -1.51% | 12,639,103 | 21.07B |
| 33 | EW | Edwards Lifesciences Corporation | 60.57B | -1.65% | 4,270,668 | 6.67B |
| 34 | ARGX | argenx SE | 60.21B | -0.33% | 409,565 | 5.92B |
| 35 | BDX | Becton, Dickinson and Company | 58.75B | -0.36% | 2,248,792 | 19.46B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 54.38B | -1.50% | 397,014 | 4.66B |
| 37 | HUM | Humana Inc. | 53.22B | -3.94% | 1,863,843 | 154.19B |
| 38 | TEVA | Teva Pharmaceutical Industries Limited | 49.73B | 0.12% | 7,009,594 | 17.23B |
| 39 | MDLN | Medline Inc. | 49.57B | -3.79% | 9,037,750 | 30.68B |
| 40 | A | Agilent Technologies, Inc. | 48.57B | -0.37% | 2,464,047 | 7.37B |
| 41 | ONC | BeOne Medicines AG | 47.20B | 0.47% | 224,201 | 6.45B |
| 42 | VEEV | Veeva Systems Inc. | 46.69B | -3.64% | 1,236,860 | 3.46B |
| 43 | WAT | Waters Corporation | 44.16B | -0.91% | 584,242 | 5.61B |
| 44 | IQV | IQVIA Holdings Inc. | 42.43B | -2.75% | 1,709,512 | 17.31B |
| 45 | NTRA | Natera, Inc. | 41.70B | -0.31% | 2,242,620 | 2.91B |
| 46 | RPRX | Royalty Pharma plc | 39.39B | 0.22% | 2,620,761 | 2.62B |
| 47 | HLN | Haleon plc | 39.15B | -1.58% | 11,882,139 | 14.80B |
| 48 | BIIB | Biogen Inc. | 37.07B | -0.33% | 968,744 | 10.30B |
| 49 | GEHC | GE HealthCare Technologies Inc. | 37.00B | -1.35% | 2,855,606 | 21.64B |
| 50 | CNC | Centene Corporation | 35.97B | -2.82% | 5,942,618 | 180.41B |
| 51 | ALC | Alcon Inc. | 35.64B | 0.67% | 4,758,287 | 10.98B |
| 52 | RVMD | Revolution Medicines, Inc. | 35.18B | -2.52% | 2,508,802 | 197.56M |
| 53 | MTD | Mettler-Toledo International Inc. | 34.03B | -0.96% | 129,984 | 4.20B |
| 54 | ZTS | Zoetis Inc. | 33.91B | -1.10% | 3,351,612 | 9.49B |
| 55 | RMD | ResMed Inc. | 33.47B | -0.11% | 1,339,426 | 5.73B |
| 56 | GMAB | Genmab A/S | 32.89B | 0.72% | 3,303,116 | 4.30B |
| 57 | ILMN | Illumina, Inc. | 30.67B | 2.43% | 1,638,132 | 4.54B |
| 58 | DXCM | DexCom, Inc. | 30.59B | 0.51% | 3,418,603 | 5.10B |
| 59 | LH | Labcorp Holdings Inc. | 29.89B | -1.15% | 715,262 | 14.59B |
| 60 | PHG | Koninklijke Philips N.V. | 28.99B | -0.88% | 930,706 | 20.16B |
| 61 | WST | West Pharmaceutical Services, Inc. | 28.85B | -0.89% | 494,022 | 3.40B |
| 62 | DGX | Quest Diagnostics Incorporated | 28.22B | -2.17% | 936,034 | 11.84B |
| 63 | ROIV | Roivant Sciences Ltd. | 28.05B | 0.27% | 8,414,059 | 41.08M |
| 64 | INSM | Insmed Incorporated | 26.73B | -0.84% | 2,397,541 | 1.52B |
| 65 | STE | STERIS plc | 25.00B | -1.44% | 687,423 | 6.17B |
| 66 | UTHR | United Therapeutics Corporation | 24.88B | -0.62% | 322,201 | 3.19B |
| 67 | INCY | Incyte Corporation | 24.27B | -0.99% | 2,152,182 | 6.01B |
| 68 | VTRS | Viatris Inc. | 23.43B | -1.45% | 10,382,164 | 14.73B |
| 69 | THC | Tenet Healthcare Corporation | 22.48B | -3.12% | 626,522 | 22.15B |
| 70 | BNTX | BioNTech SE | 21.02B | -0.54% | 1,090,201 | 2.75B |
| 71 | ALNY | Alnylam Pharmaceuticals, Inc. | 20.97B | -2.00% | 2,046,277 | 5.01B |
| 72 | GH | Guardant Health, Inc. | 19.39B | -0.49% | 1,929,501 | 1.28B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 19.32B | 0.69% | 3,356,583 | 8.57B |
| 74 | MEDP | Medpace Holdings, Inc. | 18.25B | 0.64% | 175,816 | 2.84B |
| 75 | ASND | Ascendis Pharma A/S | 17.79B | -0.17% | 585,236 | 1.37B |
| 76 | NBIX | Neurocrine Biosciences, Inc. | 16.80B | 0.42% | 1,022,636 | 3.70B |
| 77 | EXEL | Exelixis, Inc. | 16.71B | 2.09% | 2,723,326 | 2.50B |
| 78 | RVTY | Revvity, Inc. | 16.50B | -0.69% | 1,510,763 | 2.94B |
| 79 | CRL | Charles River Laboratories International, Inc. | 15.91B | -1.03% | 695,573 | 3.98B |
| 80 | JAZZ | Jazz Pharmaceuticals plc | 15.46B | 0.42% | 499,354 | 4.72B |
| 81 | BBIO | BridgeBio Pharma, Inc. | 14.96B | -0.75% | 2,812,125 | 945.54M |
| 82 | SOLV | Solventum Corporation | 14.61B | -2.89% | 724,484 | 8.16B |
| 83 | ICLR | ICON Public Limited Company | 14.60B | 1.79% | 662,784 | 8.23B |
| 84 | BTSG | BrightSpring Health Services, Inc. | 14.56B | -2.07% | 2,094,755 | 15.25B |
| 85 | GKOS | Glaukos Corporation | 14.39B | -0.70% | 712,622 | 690.33M |
| 86 | EHC | Encompass Health Corporation | 13.54B | -2.92% | 917,721 | 6.34B |
| 87 | BAX | Baxter International Inc. | 13.33B | 0.90% | 4,164,197 | 11.61B |
| 88 | ELAN | Elanco Animal Health Incorporated | 12.92B | -2.10% | 3,720,487 | 5.15B |
| 89 | PEN | Penumbra, Inc. | 12.58B | -0.47% | 365,922 | 1.56B |
| 90 | SNN | Smith & Nephew plc | 12.55B | -1.52% | 1,411,954 | 6.30B |
| 91 | RDY | Dr. Reddy's Laboratories Limited | 12.45B | 0.68% | 1,422,104 | 3.44B |
| 92 | TEM | Tempus AI, Inc. | 11.56B | -2.11% | 5,541,641 | 1.51B |
| 93 | COO | The Cooper Companies, Inc. | 11.55B | -1.86% | 1,776,366 | 4.24B |
| 94 | MOH | Molina Healthcare, Inc. | 11.52B | -5.11% | 843,661 | 42.08B |
| 95 | ALGN | Align Technology, Inc. | 11.52B | -1.53% | 1,018,764 | 4.16B |
| 96 | TECH | Bio-Techne Corporation | 11.41B | -0.20% | 5,692,257 | 1.23B |
| 97 | BMRN | BioMarin Pharmaceutical Inc. | 11.33B | 0.90% | 2,251,557 | 3.66B |
| 98 | FMS | Fresenius Medical Care AG | 11.17B | -0.75% | 872,961 | 22.12B |
| 99 | UHS | Universal Health Services, Inc. | 11.07B | -2.94% | 581,760 | 18.35B |
| 100 | MTRI | Mentari Therapeutics, Inc. | 10.95B | -8.30% | 170,630 | - |
| 101 | HALO | Halozyme Therapeutics, Inc. | 10.94B | -0.53% | 1,768,020 | 1.80B |
| 102 | DVA | DaVita Inc. | 10.89B | -0.64% | 455,211 | 14.17B |
| 103 | ENSG | The Ensign Group, Inc. | 10.75B | -1.31% | 244,771 | 5.67B |
| 104 | KYMR | Kymera Therapeutics, Inc. | 10.38B | -3.42% | 855,076 | 102.24M |
| 105 | RGEN | Repligen Corporation | 10.37B | -0.31% | 770,853 | 805.61M |
| 106 | AVTR | Avantor, Inc. | 10.28B | -0.95% | 5,930,471 | 6.64B |
| 107 | QGEN | Qiagen N.V. | 10.27B | -0.12% | 2,205,834 | 2.12B |
| 108 | PODD | Insulet Corporation | 10.08B | 0.03% | 1,367,726 | 3.19B |
| 109 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.81B | -0.44% | 364,666 | 1.43B |
| 110 | BIO | Bio-Rad Laboratories, Inc. | 9.65B | -0.42% | 202,620 | 2.59B |
| 111 | PCVX | Vaxcyte, Inc. | 9.40B | -3.57% | 1,059,256 | - |
| 112 | BRKR | Bruker Corporation | 9.38B | 1.35% | 1,875,117 | 3.51B |
| 113 | HNGE | Hinge Health, Inc. | 9.31B | -5.59% | 1,116,515 | 800.82M |
| 114 | GMED | Globus Medical, Inc. | 9.29B | -0.52% | 1,139,947 | 3.14B |
| 115 | OSCR | Oscar Health, Inc. | 9.26B | -4.76% | 4,175,015 | 17.47B |
| 116 | HSIC | Henry Schein, Inc. | 9.16B | -2.45% | 1,517,818 | 13.73B |
| 117 | SYRE | Spyre Therapeutics, Inc. | 8.92B | -5.51% | 1,078,768 | - |
| 118 | ATR | AptarGroup, Inc. | 8.90B | -1.97% | 367,531 | 3.99B |
| 119 | TGTX | TG Therapeutics, Inc. | 8.78B | -0.10% | 1,712,294 | 897.76M |
| 120 | KRYS | Krystal Biotech, Inc. | 8.78B | -0.57% | 96,095 | 470.03M |
| 121 | PRAX | Praxis Precision Medicines, Inc. | 8.54B | -1.56% | 836,506 | 7.46M |
| 122 | SMMT | Summit Therapeutics Inc. | 8.53B | -9.77% | 13,097,301 | - |
| 123 | HQY | HealthEquity, Inc. | 8.43B | -2.54% | 591,398 | 1.36B |
| 124 | PTGX | Protagonist Therapeutics, Inc. | 8.14B | -0.08% | 447,246 | 551.69M |
| 125 | RYTM | Rhythm Pharmaceuticals, Inc. | 8.09B | 8.54% | 2,514,292 | 280.75M |
| 126 | PACS | PACS Group, Inc. | 7.70B | -0.96% | 484,174 | 5.71B |
| 127 | CORT | Corcept Therapeutics Incorporated | 7.66B | 1.16% | 985,523 | 963.65M |
| 128 | ALKS | Alkermes plc | 7.64B | -2.26% | 915,871 | 1.75B |
| 129 | GRFS | Grifols, S.A. | 7.50B | -1.37% | 624,687 | 8.63B |
| 130 | KNSA | Kiniksa Pharmaceuticals International, plc | 7.48B | 1.02% | 387,702 | 945.96M |
| 131 | BLCO | Bausch + Lomb Corporation | 7.44B | -0.31% | 582,025 | 5.42B |
| 132 | TXG | 10x Genomics, Inc. | 7.40B | 2.36% | 2,863,473 | 618.58M |
| 133 | AMRX | Amneal Pharmaceuticals, Inc. | 7.36B | -0.45% | 2,311,288 | 3.20B |
| 134 | ABVX | ABIVAX Société Anonyme | 7.24B | -1.82% | 1,372,625 | 5.33M |
| 135 | CYTK | Cytokinetics, Incorporated | 7.20B | -2.75% | 2,711,971 | 113.29M |
| 136 | AXSM | Axsome Therapeutics, Inc. | 7.16B | -0.67% | 517,181 | 865.27M |
| 137 | CHE | Chemed Corporation | 7.10B | -0.34% | 147,554 | 2.66B |
| 138 | CGON | CG Oncology, Inc. | 7.06B | -6.82% | 3,160,087 | 6.17M |
| 139 | TWST | Twist Bioscience Corporation | 7.03B | 6.71% | 2,061,731 | 459.43M |
| 140 | IMVT | Immunovant, Inc. | 6.88B | -0.15% | 926,701 | - |
| 141 | IBRX | ImmunityBio, Inc. | 6.66B | 4.68% | 11,402,064 | 182.57M |
| 142 | LNTH | Lantheus Holdings, Inc. | 6.66B | 0.09% | 657,057 | 1.56B |
| 143 | ORKA | Oruka Therapeutics, Inc. | 6.53B | -2.94% | 779,875 | - |
| 144 | BLTE | Belite Bio, Inc | 6.36B | -2.92% | 86,517 | - |
| 145 | TFX | Teleflex Incorporated | 6.34B | 1.78% | 1,588,708 | 2.26B |
| 146 | KOD | Kodiak Sciences Inc. | 6.33B | -3.67% | 819,706 | - |
| 147 | ARWR | Arrowhead Pharmaceuticals, Inc. | 6.08B | -2.76% | 3,097,697 | 450.82M |
| 148 | SUPN | Supernus, Inc. | 6.04B | 0.83% | 2,808,819 | 1.37B |
| 149 | MIRM | Mirum Pharmaceuticals, Inc. | 6.00B | 0.43% | 377,662 | 670.78M |
| 150 | RDNT | RadNet, Inc. | 5.90B | -2.52% | 393,565 | 2.38B |
| 151 | LGND | Ligand Pharmaceuticals Incorporated | 5.88B | -2.61% | 293,626 | 253.83M |
| 152 | CAI | Caris Life Sciences, Inc. | 5.72B | -5.07% | 4,868,336 | 1.05B |
| 153 | DOCS | Doximity, Inc. | 5.55B | -5.07% | 2,763,424 | 661.58M |
| 154 | SRRK | Scholar Rock Holding Corporation | 5.51B | 1.43% | 2,330,635 | 570.00K |
| 155 | HAE | Haemonetics Corporation | 5.51B | -0.26% | 814,182 | 1.38B |
| 156 | LFST | LifeStance Health Group, Inc. | 5.38B | -2.28% | 6,321,358 | 1.68B |
| 157 | CON | Concentra Group Holdings Parent, Inc. | 5.36B | -2.49% | 680,715 | 2.34B |
| 158 | WAY | Waystar Holding Corp. | 5.33B | -1.42% | 2,959,429 | 1.26B |
| 159 | MANE | Veradermics, Incorporated | 5.30B | -1.93% | 400,545 | - |
| 160 | LQDA | Liquidia Corporation | 5.12B | 0.75% | 1,804,120 | 621.87M |
| 161 | LIVN | LivaNova PLC | 5.07B | -0.45% | 539,300 | 1.51B |
| 162 | MMSI | Merit Medical Systems, Inc. | 5.06B | -2.15% | 474,153 | 1.61B |
| 163 | PTCT | PTC Therapeutics, Inc. | 5.05B | -0.85% | 1,077,746 | 1.16B |
| 164 | MMED | MiniMed Group, Inc. | 5.00B | -4.66% | 5,007,031 | 3.22B |
| 165 | TVTX | Travere Therapeutics, Inc. | 4.91B | 2.86% | 1,397,105 | 651.03M |
| 166 | DNTH | Dianthus Therapeutics, Inc. | 4.89B | -3.10% | 548,489 | 2.72M |
| 167 | ERAS | Erasca, Inc. | 4.88B | -7.94% | 8,733,050 | - |
| 168 | COGT | Cogent Biosciences, Inc. | 4.85B | 1.51% | 3,329,663 | - |
| 169 | GRAL | GRAIL, Inc. | 4.76B | 0.32% | 699,628 | 166.60M |
| 170 | OPCH | Option Care Health, Inc. | 4.74B | -0.27% | 3,389,342 | 5.75B |
| 171 | BLLN | BillionToOne, Inc. | 4.66B | 1.36% | 778,788 | 436.87M |
| 172 | ADPT | Adaptive Biotechnologies Corporation | 4.61B | 2.22% | 1,885,935 | 298.01M |
| 173 | EWTX | Edgewise Therapeutics, Inc. | 4.61B | -3.66% | 1,401,191 | - |
| 174 | SHC | Sotera Health Company | 4.58B | -1.35% | 2,611,721 | 1.23B |
| 175 | IONS | Ionis Pharmaceuticals, Inc. | 4.48B | -3.87% | 4,309,301 | 960.09M |
| 176 | ICUI | ICU Medical, Inc. | 4.43B | -2.55% | 289,366 | 2.18B |
| 177 | STVN | Stevanato Group S.p.A. | 4.17B | -1.58% | 813,315 | 1.42B |
| 178 | HTFL | HeartFlow, Inc. | 4.14B | 0.53% | 1,358,494 | 238.66M |
| 179 | HIMS | Hims & Hers Health, Inc. | 4.11B | -5.44% | 13,046,193 | 2.87B |
| 180 | DFTX | Definium Therapeutics, Inc. | 4.02B | -2.57% | 1,923,832 | - |
| 181 | CDNA | CareDx, Inc. | 3.92B | 1.17% | 813,102 | 497.40M |
| 182 | SLS | SELLAS Life Sciences Group, Inc. | 3.91B | 156.49% | 116,788,069 | - |
| 183 | CRSP | CRISPR Therapeutics AG | 3.89B | -0.54% | 4,105,484 | 25.17M |
| 184 | TARS | Tarsus Pharmaceuticals, Inc. | 3.86B | -0.55% | 473,837 | 682.20M |
| 185 | XENE | Xenon Pharmaceuticals Inc. | 3.81B | -1.18% | 2,121,962 | 7.50M |
| 186 | NVST | Envista Holdings Corporation | 3.80B | -1.29% | 2,989,725 | 2.88B |
| 187 | TNGX | Tango Therapeutics, Inc. | 3.74B | -8.56% | 2,044,327 | 53.81M |
| 188 | OGN | Organon & Co. | 3.65B | 0.00% | 4,163,430 | 6.10B |
| 189 | RLAY | Relay Therapeutics, Inc. | 3.64B | -4.57% | 2,568,065 | 10.35M |
| 190 | ABCL | AbCellera Biologics Inc. | 3.60B | -0.81% | 2,676,434 | 67.85M |
| 191 | PBLS | Parabilis Medicines, Inc. | 3.55B | -0.40% | 480,472 | 2.26M |
| 192 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.54B | -0.86% | 1,175,909 | -665.00K |
| 193 | ACHC | Acadia Healthcare Company, Inc. | 3.53B | -1.96% | 1,924,399 | 3.41B |
| 194 | IOVA | Iovance Biotherapeutics, Inc. | 3.49B | -0.13% | 8,810,308 | 378.98M |
| 195 | SGRY | Surgery Partners, Inc. | 3.48B | 0.28% | 2,034,134 | 3.36B |
| 196 | IRON | Disc Medicine, Inc. | 3.48B | -0.14% | 457,977 | - |
| 197 | ARQT | Arcutis Biotherapeutics, Inc. | 3.46B | 0.66% | 1,309,801 | 508.68M |
| 198 | ELVN | Enliven Therapeutics, Inc. | 3.44B | -1.70% | 652,265 | - |
| 199 | VKTX | Viking Therapeutics, Inc. | 3.43B | 0.26% | 4,548,881 | - |
| 200 | VRDN | Viridian Therapeutics, Inc. | 3.41B | 0.89% | 1,710,265 | 26.31M |
| 201 | AXGN | Axogen, Inc. | 3.31B | 0.00% | 1,352,173 | 266.93M |
| 202 | PLSE | Pulse Biosciences, Inc. | 3.30B | -3.21% | 628,569 | 1.49M |
| 203 | TMDX | TransMedics Group, Inc. | 3.26B | 1.81% | 958,604 | 727.65M |
| 204 | NHC | National HealthCare Corporation | 3.24B | -0.11% | 67,920 | 1.58B |
| 205 | WRBY | Warby Parker Inc. | 3.22B | -1.16% | 4,281,870 | 934.66M |
| 206 | PRVA | Privia Health Group, Inc. | 3.20B | -0.95% | 1,094,382 | 2.43B |
| 207 | GRDN | Guardian Pharmacy Services, Inc. | 3.19B | 1.87% | 333,245 | 1.46B |
| 208 | BHC | Bausch Health Companies Inc. | 3.17B | 0.53% | 2,658,207 | 11.11B |
| 209 | ACAD | Acadia Pharmaceuticals Inc. | 3.17B | -1.90% | 1,533,596 | 1.20B |
| 210 | LEGN | Legend Biotech Corporation | 3.12B | 0.75% | 3,023,476 | 1.36B |
| 211 | XERS | Xeris Biopharma Holdings, Inc. | 3.07B | 0.54% | 2,657,538 | 368.26M |
| 212 | TLX | Telix Pharmaceuticals Limited | 3.04B | -0.73% | 247,702 | 890.79M |
| 213 | ADMA | ADMA Biologics, Inc. | 3.03B | 1.26% | 2,945,474 | 519.15M |
| 214 | IRTC | iRhythm Holdings, Inc. | 3.01B | -1.43% | 587,466 | 854.04M |
| 215 | DYN | Dyne Therapeutics, Inc. | 3.00B | -4.04% | 2,058,008 | - |
| 216 | VCEL | Vericel Corporation | 2.96B | 0.82% | 555,288 | 324.17M |
| 217 | DNLI | Denali Therapeutics Inc. | 2.88B | -0.47% | 1,130,975 | 21.38M |
| 218 | CELC | Celcuity Inc. | 2.85B | -4.19% | 2,206,899 | - |
| 219 | ATRC | AtriCure, Inc. | 2.80B | -0.52% | 611,136 | 589.80M |
| 220 | PGNY | Progyny, Inc. | 2.71B | -1.06% | 895,974 | 1.34B |
| 221 | IDYA | IDEAYA Biosciences, Inc. | 2.65B | -9.72% | 2,042,906 | 36.54M |
| 222 | ZLAB | Zai Lab Limited | 2.65B | 0.23% | 690,590 | 441.73M |
| 223 | MBX | MBX Biosciences, Inc. | 2.64B | 0.04% | 355,782 | - |
| 224 | XNCR | Xencor, Inc. | 2.59B | -2.51% | 1,616,761 | 200.49M |
| 225 | AVAH | Aveanna Healthcare Holdings Inc. | 2.55B | 0.21% | 3,386,885 | 2.68B |
| 226 | CLOV | Clover Health Investments, Corp. | 2.53B | -4.55% | 4,099,286 | 2.74B |
| 227 | ARDT | Ardent Health, Inc. | 2.50B | -1.88% | 450,106 | 6.45B |
| 228 | HCM | HUTCHMED (China) Limited | 2.49B | -2.55% | 42,310 | 549.12M |
| 229 | NEOG | Neogen Corporation | 2.38B | 0.28% | 2,758,293 | 884.00M |
| 230 | MD | Pediatrix Medical Group, Inc. | 2.37B | -2.32% | 428,562 | 1.96B |
| 231 | RCUS | Arcus Biosciences, Inc. | 2.36B | -2.79% | 1,915,121 | 100.00M |
| 232 | NAMS | NewAmsterdam Pharma Company N.V. | 2.33B | -0.31% | 1,364,031 | 25.94M |
| 233 | UFPT | UFP Technologies, Inc. | 2.31B | -0.26% | 90,016 | 649.52M |
| 234 | PBH | Prestige Consumer Healthcare Inc. | 2.28B | 0.31% | 597,835 | 1.17B |
| 235 | PHVS | Pharvaris N.V. | 2.27B | -0.37% | 241,398 | - |
| 236 | RGC | Regencell Bioscience Holdings Limited | 2.26B | -3.60% | 89,601 | - |
| 237 | ADUS | Addus HomeCare Corporation | 2.22B | -2.21% | 124,641 | 1.50B |
| 238 | LKFT | Lakefront Biotherapeutics NV | 2.19B | -1.09% | 241,175 | 1.13B |
| 239 | CLDX | Celldex Therapeutics, Inc. | 2.19B | -2.45% | 519,916 | 158.00K |
| 240 | PRGO | Perrigo Company plc | 2.19B | -2.47% | 1,719,647 | 4.09B |
| 241 | ALMR | Alamar Biosciences, Inc. | 2.13B | 0.33% | 466,672 | 114.05M |
| 242 | BKD | Brookdale Senior Living Inc. | 2.11B | -1.73% | 13,360,456 | 2.86B |
| 243 | PVLA | Palvella Therapeutics, Inc. | 2.10B | -0.57% | 211,070 | - |
| 244 | ESTA | Establishment Labs Holdings Inc. | 2.07B | -0.49% | 352,473 | 264.03M |
| 245 | AUPH | Aurinia Pharmaceuticals Inc. | 2.07B | -0.42% | 833,087 | 321.74M |
| 246 | BEAM | Beam Therapeutics Inc. | 2.06B | -1.36% | 4,123,818 | 146.64M |
| 247 | IMNM | Immunome, Inc. | 2.03B | -2.36% | 1,026,454 | 4.02M |
| 248 | BHVN | Biohaven Ltd. | 2.00B | -4.06% | 1,567,472 | - |
| 249 | NEO | NeoGenomics, Inc. | 1.97B | -0.97% | 1,020,817 | 787.75M |
| 250 | VCYT | Veracyte, Inc. | 1.95B | 0.90% | 2,908,592 | 581.78M |
| 251 | TRLV | Trulieve Cannabis Corp. | 1.94B | -2.61% | 1,486,318 | 1.08B |
| 252 | HRMY | Harmony Biosciences Holdings, Inc. | 1.93B | -0.06% | 522,281 | 989.36M |
| 253 | BCRX | BioCryst Pharmaceuticals, Inc. | 1.93B | 0.87% | 3,706,871 | 961.51M |
| 254 | AGL | agilon health, inc. | 1.93B | -1.58% | 211,192 | 6.00B |
| 255 | TRVI | Trevi Therapeutics, Inc. | 1.93B | 1.73% | 1,681,225 | - |
| 256 | SDGR | Schrödinger, Inc. | 1.93B | -6.25% | 1,189,398 | 269.20M |
| 257 | AZTA | Azenta, Inc. | 1.91B | -3.01% | 1,411,915 | 621.70M |
| 258 | SEPN | Septerna, Inc. | 1.90B | -3.98% | 271,555 | 96.27M |
| 259 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.89B | -1.49% | 1,609,030 | 213.00M |
| 260 | VERA | Vera Therapeutics, Inc. | 1.89B | -2.86% | 1,192,599 | 10.28M |
| 261 | FTRE | Fortrea Holdings Inc. | 1.89B | -0.93% | 2,118,287 | 2.67B |
| 262 | ZBIO | Zenas BioPharma, Inc. | 1.88B | -0.57% | 447,440 | 11.00M |
| 263 | REPL | Replimune Group, Inc. | 1.87B | -8.06% | 2,432,975 | - |
| 264 | COAG | Hemab Therapeutics Holdings, Inc. | 1.85B | 1.42% | 281,492 | - |
| 265 | ETON | Eton Pharmaceuticals, Inc. | 1.83B | -0.41% | 526,139 | 141.06M |
| 266 | TRAX | First Tracks Biotherapeutics, Inc. | 1.83B | -6.59% | 586,203 | - |
| 267 | LYCA | Lycia Therapeutics, Inc. | 1.80B | 9.33% | 483,796 | 4.44M |
| 268 | MAZE | Maze Therapeutics, Inc. | 1.80B | -3.16% | 601,636 | 20.00M |
| 269 | AGIO | Agios Pharmaceuticals, Inc. | 1.79B | -0.88% | 630,568 | 140.84M |
| 270 | ZYME | Zymeworks Inc. | 1.78B | -2.34% | 569,909 | 265.97M |
| 271 | LMAT | LeMaitre Vascular, Inc. | 1.74B | -1.13% | 190,501 | 269.36M |
| 272 | STOK | Stoke Therapeutics, Inc. | 1.73B | -0.75% | 550,048 | 28.21M |
| 273 | INSP | Inspire Medical Systems, Inc. | 1.72B | 0.52% | 580,793 | 880.94M |
| 274 | XRAY | DENTSPLY SIRONA Inc. | 1.70B | -3.91% | 7,943,641 | 3.58B |
| 275 | RARE | Ultragenyx Pharmaceutical Inc. | 1.70B | 4.97% | 5,587,231 | 730.00M |
| 276 | RXRX | Recursion Pharmaceuticals, Inc. | 1.69B | -6.54% | 40,501,268 | 68.23M |
| 277 | CERT | Certara, Inc. | 1.69B | -2.85% | 2,283,224 | 425.76M |
| 278 | KMTS | Kestra Medical Technologies, Ltd. | 1.68B | 0.97% | 215,379 | 106.73M |
| 279 | HCSG | Healthcare Services Group, Inc. | 1.67B | -0.64% | 453,616 | 1.88B |
| 280 | ASTH | Astrana Health, Inc. | 1.64B | -2.65% | 324,135 | 3.91B |
| 281 | PSNL | Personalis, Inc. | 1.60B | 0.03% | 3,134,961 | 80.77M |
| 282 | ALHC | Alignment Healthcare, Inc. | 1.60B | 2.14% | 5,873,300 | 4.94B |
| 283 | KLRA | Kailera Therapeutics, Inc. | 1.59B | -2.82% | 510,049 | - |
| 284 | SRPT | Sarepta Therapeutics, Inc. | 1.59B | -2.28% | 2,373,629 | 1.96B |
| 285 | VIR | Vir Biotechnology, Inc. | 1.58B | -3.50% | 3,475,625 | 302.80M |
| 286 | SNDA | Sonida Senior Living, Inc. | 1.57B | -1.25% | 540,507 | 593.56M |
| 287 | ENOV | Enovis Corporation | 1.57B | -2.54% | 845,596 | 2.31B |
| 288 | OMCL | Omnicell, Inc. | 1.57B | -3.98% | 478,940 | 1.24B |
| 289 | ALVO | Alvotech | 1.56B | -0.57% | 1,515,206 | 492.31M |
| 290 | NRIX | Nurix Therapeutics, Inc. | 1.56B | -3.29% | 1,915,212 | 701.94M |
| 291 | TDOC | Teladoc Health, Inc. | 1.55B | -2.36% | 3,767,916 | 2.47B |
| 292 | BFLY | Butterfly Network, Inc. | 1.54B | 0.70% | 4,271,424 | 123.26M |
| 293 | PGEN | Precigen, Inc. | 1.54B | -0.35% | 4,090,231 | 156.94M |
| 294 | BRVE | Braveheart Bio, Inc. | 1.53B | -3.80% | 949,683 | - |
| 295 | WWB | Windward Bio Group AG | 1.51B | -13.18% | 241,420 | - |
| 296 | MESO | Mesoblast Limited | 1.50B | -4.54% | 245,827 | 120.25M |
| 297 | ANIP | ANI Pharmaceuticals, Inc. | 1.48B | -1.26% | 723,871 | 1.04B |
| 298 | ADRX | ADARx Pharmaceuticals, Inc. | 1.48B | -0.93% | 696,890 | 6.13M |
| 299 | KRSA | Korsana Biosciences, Inc. | 1.48B | -0.73% | 202,246 | - |
| 300 | AMN | AMN Healthcare Services, Inc. | 1.47B | -3.83% | 494,080 | 3.52B |
| 301 | USPH | U.S. Physical Therapy, Inc. | 1.46B | -1.58% | 260,448 | 829.86M |
| 302 | PCRX | Pacira BioSciences, Inc. | 1.46B | 0.00% | - | 743.30M |
| 303 | URGN | UroGen Pharma Ltd. | 1.46B | 5.78% | 2,661,468 | 250.25M |
| 304 | QURE | uniQure N.V. | 1.46B | -5.12% | 1,213,472 | 20.17M |
| 305 | CNMD | CONMED Corporation | 1.44B | -2.01% | 294,072 | 1.37B |
| 306 | IMCR | Immunocore Holdings plc | 1.44B | -3.70% | 419,031 | 429.30M |
| 307 | WGS | GeneDx Holdings Corp. | 1.42B | -7.21% | 1,987,601 | 460.78M |
| 308 | PAHC | Phibro Animal Health Corporation | 1.42B | -0.31% | 99,594 | 1.54B |
| 309 | NBTX | Nanobiotix S.A. | 1.41B | -4.08% | 106,499 | 13.15M |
| 310 | RAPP | Rapport Therapeutics, Inc. | 1.41B | -4.27% | 522,667 | 20.00M |
| 311 | LMRI | Lumexa Imaging Holdings, Inc. | 1.40B | -1.22% | 278,048 | 1.06B |
| 312 | DMRA | Damora Therapeutics, Inc. | 1.40B | 0.29% | 395,991 | - |
| 313 | NUVB | Nuvation Bio Inc. | 1.38B | 1.69% | 5,752,712 | 201.73M |
| 314 | NTLA | Intellia Therapeutics, Inc. | 1.37B | -0.81% | 7,566,743 | 52.89M |
| 315 | PRCT | PROCEPT BioRobotics Corporation | 1.37B | 1.10% | 1,335,346 | 352.31M |
| 316 | ANAB | AnaptysBio, Inc. | 1.36B | -0.22% | 597,687 | 60.04M |
| 317 | TYRA | Tyra Biosciences, Inc. | 1.35B | -0.71% | 689,837 | - |
| 318 | OCUL | Ocular Therapeutix, Inc. | 1.32B | 0.08% | 6,296,593 | 50.38M |
| 319 | NVAX | Novavax, Inc. | 1.31B | -1.30% | 3,502,091 | 411.65M |
| 320 | ABSI | Absci Corporation | 1.31B | 1.40% | 4,680,350 | 1.49M |
| 321 | MNKD | MannKind Corporation | 1.31B | 2.91% | 3,397,341 | 413.37M |
| 322 | TSHA | Taysha Gene Therapies, Inc. | 1.31B | -1.35% | 1,984,252 | 5.49M |
| 323 | LBRX | LB Pharmaceuticals Inc | 1.31B | -6.19% | 396,089 | - |
| 324 | NVCR | NovoCure Limited | 1.30B | -1.33% | 1,442,789 | 725.39M |
| 325 | GPCR | Structure Therapeutics Inc. | 1.30B | -2.10% | 582,577 | - |
| 326 | INVA | Innoviva, Inc. | 1.30B | -1.00% | 988,411 | 438.32M |
| 327 | INNV | InnovAge Holding Corp. | 1.28B | -1.77% | 291,164 | 1.02B |
| 328 | STAA | STAAR Surgical Company | 1.28B | -1.67% | 420,302 | 328.27M |
| 329 | PNTG | The Pennant Group, Inc. | 1.28B | -1.32% | 416,840 | 1.17B |
| 330 | MLYS | Mineralys Therapeutics, Inc. | 1.28B | -0.28% | 995,145 | - |
| 331 | GENB | Generate Biomedicines, Inc. | 1.27B | -6.58% | 866,762 | 21.07M |
| 332 | GHRS | GH Research PLC | 1.25B | -3.15% | 297,963 | - |
| 333 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.24B | -0.07% | 409,693 | 745.79M |
| 334 | AVLN | Avalyn Pharma Inc. | 1.24B | -6.25% | 453,011 | - |
| 335 | KARD | Kardigan, Inc. | 1.23B | 2.49% | 250,641 | - |
| 336 | SLN | Silence Therapeutics plc | 1.23B | 0.03% | 1,211,320 | 456.00K |
| 337 | NKTR | Nektar Therapeutics | 1.23B | -1.32% | 706,625 | 52.19M |
| 338 | OPK | OPKO Health, Inc. | 1.21B | 0.31% | 3,027,357 | 654.10M |
| 339 | SVRA | Savara Inc. | 1.21B | 0.22% | 3,759,135 | - |
| 340 | AAPG | Ascentage Pharma Group International | 1.19B | -0.53% | 3,047 | 94.61M |
| 341 | TNDM | Tandem Diabetes Care, Inc. | 1.19B | -7.90% | 2,218,514 | 1.08B |
| 342 | GDRX | GoodRx Holdings, Inc. | 1.19B | -0.85% | 1,400,264 | 785.23M |
| 343 | NUTX | Nutex Health Inc. | 1.18B | 1.59% | 159,784 | 796.53M |
| 344 | CRON | Cronos Group Inc. | 1.18B | -1.99% | 833,914 | 206.20M |
| 345 | CMPS | COMPASS Pathways plc | 1.13B | -3.45% | 2,642,176 | - |
| 346 | VOR | Vor Biopharma Inc. | 1.12B | -4.27% | 826,246 | - |
| 347 | DRTS | Alpha Tau Medical Ltd. | 1.12B | 0.92% | 1,074,936 | - |
| 348 | AHG | Akso Health Group | 1.11B | -2.26% | 2,480 | 13.83M |
| 349 | HROW | Harrow, Inc. | 1.11B | 1.39% | 452,662 | 303.25M |
| 350 | INBX | Inhibrx Biosciences, Inc. | 1.10B | -4.44% | 300,126 | 2.00M |
| 351 | ATEC | Alphatec Holdings, Inc. | 1.08B | 2.51% | 3,114,463 | 839.72M |
| 352 | IRMD | IRADIMED CORPORATION | 1.07B | -1.00% | 63,164 | 89.34M |
| 353 | JBIO | Jade Biosciences, Inc. | 1.07B | 0.59% | 2,078,544 | - |
| 354 | SGP | SpyGlass Pharma, Inc. | 1.06B | -1.71% | 81,199 | - |
| 355 | FRNM | Freenome, Inc. | 1.06B | -2.58% | 523,799 | 217.86M |
| 356 | IART | Integra LifeSciences Holdings Corporation | 1.05B | -3.15% | 1,169,741 | 1.66B |
| 357 | SIBN | SI-BONE, Inc. | 1.04B | -1.15% | 770,581 | 220.65M |
| 358 | CSTL | Castle Biosciences, Inc. | 1.01B | 0.50% | 339,176 | 377.13M |
| 359 | GMRS | GMR Solutions Inc. | 1.01B | -4.35% | 1,063,843 | 5.97B |
| 360 | CBLL | CeriBell, Inc. | 1.01B | -1.85% | 428,153 | 108.72M |
| 361 | OMER | Omeros Corporation | 1.01B | -16.67% | 5,336,997 | 74.36M |
| 362 | AHCO | AdaptHealth Corp. | 1.01B | -2.65% | 1,805,174 | 3.44B |
| 363 | ANRO | Alto Neuroscience, Inc. | 999.96M | -8.08% | 498,651 | - |
| 364 | SPTX | Seaport Therapeutics, Inc. | 976.40M | -4.60% | 278,246 | - |
| 365 | MLTX | MoonLake Immunotherapeutics | 958.30M | -4.01% | 1,165,376 | - |
| 366 | VSTM | Verastem, Inc. | 934.40M | -3.70% | 2,869,357 | 100.30M |
| 367 | ODTX | Odyssey Therapeutics, Inc. | 929.58M | 0.15% | 301,613 | 99.00K |
| 368 | LTGO | Latigo Biotherapeutics, Inc. | 913.61M | 9.37% | 661,606 | - |
| 369 | AKTS | Aktis Oncology, Inc. | 908.39M | 0.74% | 473,261 | 12.39M |
| 370 | AORT | Artivion, Inc. | 891.88M | -1.03% | 561,734 | 481.88M |
| 371 | BVS | Bioventus Inc. | 888.11M | 0.76% | 562,561 | 585.64M |
| 372 | OMDA | Omada Health, Inc. | 871.63M | -3.04% | 985,861 | 333.04M |
| 373 | CTY | City Therapeutics, Inc. | 869.25M | 2.89% | 321,268 | 14.34M |
| 374 | IMTX | Immatics N.V. | 861.15M | 2.11% | 3,133,707 | 49.33M |
| 375 | CRVS | Corvus Pharmaceuticals, Inc. | 857.87M | -4.06% | 923,160 | - |
| 376 | PHAR | Pharming Group N.V. | 854.95M | -2.22% | 7,946 | 386.75M |
| 377 | HSTM | HealthStream, Inc. | 846.39M | -0.18% | 200,510 | 327.95M |
| 378 | BBTX | Bambusa Therapeutics, Inc. | 844.63M | 3.75% | 174,894 | - |
| 379 | ORIC | ORIC Pharmaceuticals, Inc. | 829.22M | 6.38% | 1,999,942 | - |
| 380 | MGTX | MeiraGTx Holdings plc | 827.78M | -3.09% | 823,581 | 401.91M |
| 381 | SNDX | Syndax Pharmaceuticals, Inc. | 827.36M | 0.66% | 2,597,004 | 289.68M |
| 382 | KIDS | OrthoPediatrics Corp. | 818.82M | -0.44% | 171,802 | 264.14M |
| 383 | RIGL | Rigel Pharmaceuticals, Inc. | 809.31M | -1.72% | 195,127 | 288.21M |
| 384 | IRWD | Ironwood Pharmaceuticals, Inc. | 807.06M | 0.52% | 2,823,368 | 400.30M |
| 385 | BBNX | Beta Bionics, Inc. | 800.83M | -3.16% | 1,075,512 | 127.27M |
| 386 | ARDX | Ardelyx, Inc. | 800.62M | 3.75% | 4,391,495 | 468.22M |
| 387 | COLL | Collegium Pharmaceutical, Inc. | 794.91M | 0.59% | 365,218 | 815.19M |
| 388 | LXRX | Lexicon Pharmaceuticals, Inc. | 794.74M | 2.00% | 2,416,615 | 38.54M |
| 389 | PHR | Phreesia, Inc. | 778.68M | -2.15% | 652,274 | 507.79M |
| 390 | GLUE | Monte Rosa Therapeutics, Inc. | 773.75M | -1.15% | 1,154,360 | 70.33M |
| 391 | VREX | Varex Imaging Corporation | 763.30M | -0.11% | 1,240,858 | 865.00M |
| 392 | OBX | Obsidian Therapeutics, Inc. | 754.86M | -1.13% | 261,547 | - |
| 393 | CTKB | Cytek Biosciences, Inc. | 744.81M | 1.15% | 1,109,102 | 207.65M |
| 394 | AURA | Aura Biosciences, Inc. | 744.13M | -0.97% | 627,599 | - |
| 395 | INMD | InMode Ltd. | 743.51M | -1.63% | 589,428 | 373.60M |
| 396 | APMD | Apnimed, Inc. | 742.69M | 9.58% | 395,526 | 108.80M |
| 397 | OABI | OmniAb, Inc. | 738.78M | 3.58% | 1,261,813 | 40.21M |
| 398 | IVA | Inventiva S.A. | 729.55M | -3.01% | 2,040,881 | 2.81M |
| 399 | SGMT | Sagimet Biosciences Inc. | 704.40M | -2.57% | 843,285 | - |
| 400 | SLDB | Solid Biosciences Inc. | 697.01M | -3.63% | 1,133,946 | - |
| 401 | KURA | Kura Oncology, Inc. | 688.63M | 5.71% | 3,130,718 | 79.31M |
| 402 | PRME | Prime Medicine, Inc. | 683.46M | -8.59% | 4,492,842 | 7.06M |
| 403 | ATTO | Attovia Therapeutics, Inc. | 679.29M | 1.05% | 292,409 | 1.44M |
| 404 | QDEL | QuidelOrtho Corporation | 677.21M | -3.33% | 7,718,565 | 2.59B |
| 405 | QUIT | Achieve Life Sciences, Inc. | 676.71M | 1.49% | 1,097,726 | - |
| 406 | FLGT | Fulgent Genetics, Inc. | 675.84M | 0.48% | 273,746 | 330.28M |
| 407 | IAM | Iambic Therapeutics, Inc. | 674.51M | 20.08% | 479,638 | 18.25M |
| 408 | DCTH | Delcath Systems, Inc. | 672.98M | -2.64% | 532,476 | 109.96M |
| 409 | ANNX | Annexon, Inc. | 663.86M | -2.52% | 2,880,086 | - |
| 410 | NVCT | Nuvectis Pharma, Inc. | 661.64M | 0.68% | 181,012 | - |
| 411 | JANX | Janux Therapeutics, Inc. | 655.58M | -1.88% | 733,509 | 23.29M |
| 412 | GERN | Geron Corporation | 647.46M | 6.70% | 13,252,832 | 217.52M |
| 413 | BCAX | Bicara Therapeutics Inc. | 637.32M | -1.54% | 917,066 | - |
| 414 | SOPH | SOPHiA GENETICS SA | 635.58M | -0.27% | 469,470 | 90.97M |
| 415 | OLMA | Olema Oncology, Inc. | 632.96M | -1.83% | 1,266,240 | - |
| 416 | DSGN | Design Therapeutics, Inc. | 630.76M | -0.71% | 293,990 | - |
| 417 | ALMS | Alumis Inc. | 628.98M | -5.74% | 1,860,580 | 7.24M |
| 418 | DBVT | DBV Technologies S.A. | 625.36M | -3.41% | 165,383 | 3.74M |
| 419 | ABUS | Arbutus Biopharma Corporation | 623.90M | 0.74% | 2,214,938 | 181.49M |
| 420 | ANL | Adlai Nortye Group Ltd. | 609.20M | -5.68% | 291,782 | 18.06M |
| 421 | FDMT | 4D Molecular Therapeutics, Inc. | 608.33M | -4.43% | 812,709 | 96.06M |
| 422 | IMMX | Immix Biopharma, Inc. | 605.54M | -3.41% | 972,251 | - |
| 423 | CGEM | Cullinan Therapeutics, Inc. | 603.44M | -2.16% | 1,625,921 | - |
| 424 | TCMD | Tactile Systems Technology, Inc. | 584.00M | -1.14% | 222,195 | 356.42M |
| 425 | SGHT | Sight Sciences, Inc. | 583.02M | -0.94% | 271,333 | 88.40M |
| 426 | CLYM | Climb Bio, Inc. | 574.46M | -1.61% | 593,742 | - |
| 427 | SRZN | Surrozen, Inc. | 572.61M | -7.05% | 218,214 | 10.53M |
| 428 | PACB | Pacific Biosciences of California, Inc. | 571.09M | -0.82% | 13,307,443 | 161.39M |
| 429 | SANA | Sana Biotechnology, Inc. | 564.81M | 0.27% | 2,620,110 | - |
| 430 | WVE | Wave Life Sciences, Inc. | 560.13M | -1.05% | 2,779,849 | 70.92M |
| 431 | CBIO | Crescent Biopharma, Inc. | 559.84M | -3.11% | 214,582 | 15.00M |
| 432 | ZVRA | Zevra Therapeutics, Inc. | 559.05M | 1.57% | 836,563 | 147.76M |
| 433 | SENS | Senseonics Holdings, Inc. | 556.84M | -6.74% | 1,699,805 | 60.01M |
| 434 | AVBP | ArriVent BioPharma, Inc. | 552.14M | -7.66% | 859,442 | 5.00M |
| 435 | OBIO | Orchestra BioMed Holdings, Inc. | 549.75M | -1.90% | 551,686 | 31.21M |
| 436 | NRC | NRC Health | 549.21M | -1.71% | 79,711 | 143.79M |
| 437 | DNA | Ginkgo Bioworks Holdings, Inc. | 538.95M | -2.18% | 2,469,470 | 130.75M |
| 438 | VALN | Valneva SE | 536.70M | -1.50% | 5,954 | 163.30M |
| 439 | ACRS | Aclaris Therapeutics, Inc. | 536.11M | -6.24% | 3,097,172 | 6.40M |
| 440 | MYGN | Myriad Genetics, Inc. | 532.85M | -0.27% | 1,114,588 | 803.60M |
| 441 | ETRA | Electra Therapeutics, Inc. | 527.24M | 1.08% | 332,191 | - |
| 442 | HELP | Helus Pharma Inc. | 525.30M | -6.26% | 2,991,512 | - |
| 443 | ENTX | Entera Bio Ltd. | 524.15M | -0.33% | 186,859 | 42.00K |
| 444 | EVH | Evolent Health, Inc. | 521.98M | -4.45% | 1,479,598 | 2.34B |
| 445 | AVR | Anteris Technologies Global Corp. | 519.64M | -6.49% | 1,179,084 | 2.33M |
| 446 | INDP | Indaptus Therapeutics, Inc. | 511.43M | -3.48% | 275,728 | - |
| 447 | GYRE | Gyre Therapeutics, Inc. | 499.10M | 3.87% | 215,953 | 110.06M |
| 448 | RCEL | AVITA Medical, Inc. | 498.77M | 3.42% | 469,719 | 84.68M |
| 449 | EVO | Evotec SE | 498.76M | -7.37% | 62,403 | 815.72M |
| 450 | CAPR | Capricor Therapeutics, Inc. | 488.68M | 1.27% | 4,555,562 | 11.13M |
| 451 | CARL | Carlsmed, Inc. | 485.05M | 2.02% | 292,362 | 71.78M |
| 452 | BLSM | BlossomHill Therapeutics, Inc. | 484.72M | 11.72% | 390,257 | - |
| 453 | MNPR | Monopar Therapeutics Inc. | 484.06M | -0.75% | 114,102 | - |
| 454 | ANGO | AngioDynamics, Inc. | 484.05M | -2.29% | 304,459 | 325.38M |
| 455 | TKNO | Alpha Teknova, Inc. | 481.21M | -1.54% | 146,049 | 45.95M |
| 456 | FENC | Fennec Pharmaceuticals Inc. | 479.97M | 6.54% | 905,288 | 66.37M |
| 457 | NGNE | Neurogene Inc. | 478.40M | -0.82% | 277,140 | 925.00K |
| 458 | RGNX | REGENXBIO Inc. | 477.74M | -1.30% | 963,068 | 153.91M |
| 459 | KMDA | Kamada Ltd. | 472.82M | 0.86% | 74,667 | 196.87M |
| 460 | SRTA | Strata Critical Medical, Inc. | 468.48M | -3.23% | 1,035,521 | 280.76M |
| 461 | STTK | Shattuck Labs, Inc. | 467.97M | -1.39% | 785,566 | 1.00M |
| 462 | MDXG | MiMedx Group, Inc. | 464.77M | 0.16% | 2,043,334 | 303.73M |
| 463 | AQST | Aquestive Therapeutics, Inc. | 464.42M | -1.73% | 2,116,264 | 48.84M |
| 464 | OCS | Oculis Holding AG | 464.23M | -1.44% | 239,988 | 1.12M |
| 465 | ASMB | Assembly Biosciences, Inc. | 461.35M | 5.82% | 326,385 | 67.01M |
| 466 | DMAC | DiaMedica Therapeutics Inc. | 450.54M | 0.24% | 294,959 | - |
| 467 | ARVN | Arvinas, Inc. | 446.94M | 0.81% | 1,527,919 | 275.30M |
| 468 | EOLS | Evolus, Inc. | 444.12M | 1.21% | 669,864 | 325.47M |
| 469 | PHAT | Phathom Pharmaceuticals, Inc. | 438.45M | -6.12% | 1,060,436 | 274.88M |
| 470 | EPRX | Eupraxia Pharmaceuticals Inc. | 438.02M | -9.95% | 1,629,503 | - |
| 471 | SI | Shoulder Innovations, Inc. | 430.38M | 0.59% | 147,142 | 64.49M |
| 472 | CTMX | CytomX Therapeutics, Inc. | 424.02M | -2.02% | 2,125,673 | 14.03M |
| 473 | CADL | Candel Therapeutics, Inc. | 424.00M | -6.97% | 1,793,502 | - |
| 474 | PRTA | Prothena Corporation plc | 423.38M | 3.45% | 596,411 | 52.74M |
| 475 | RZLT | Rezolute, Inc. | 422.24M | 12.43% | 2,884,428 | - |
| 476 | MOBI | Mobia Medical, Inc. | 419.60M | -4.26% | 102,749 | 51.89M |
| 477 | OVID | Ovid Therapeutics Inc. | 418.04M | -7.71% | 2,420,712 | 1.45M |
| 478 | AVTX | Avalo Therapeutics, Inc. | 412.86M | -3.12% | 3,108,763 | 59.00K |
| 479 | TECX | Tectonic Therapeutic, Inc. | 397.83M | -3.00% | 129,771 | - |
| 480 | IRD | Opus Genetics, Inc. | 391.93M | 0.37% | 729,130 | 7.91M |
| 481 | CTEV | Claritev Corporation | 390.93M | -8.38% | 210,072 | 1.02B |
| 482 | MASS | 908 Devices Inc. | 390.87M | 2.29% | 312,902 | 65.79M |
| 483 | CERS | Cerus Corporation | 384.72M | 2.42% | 4,631,783 | 226.57M |
| 484 | ALEC | Alector, Inc. | 378.15M | -1.17% | 1,268,908 | 173.47M |
| 485 | SLBT | SL Science Holding Limited | 376.38M | -8.27% | 60,143 | 3.27M |
| 486 | CTNM | Contineum Therapeutics, Inc. | 375.18M | -1.19% | 294,106 | - |
| 487 | CRMD | CorMedix Inc. | 372.24M | -2.90% | 1,986,994 | 412.49M |
| 488 | PBYI | Puma Biotechnology, Inc. | 370.16M | -2.45% | 593,793 | 231.83M |
| 489 | SPRY | ARS Pharmaceuticals, Inc. | 368.44M | 2.09% | 1,191,121 | 122.14M |
| 490 | MPLT | MapLight Therapeutics, Inc. | 365.69M | -4.64% | 547,758 | - |
| 491 | BWAY | BrainsWay Ltd. | 362.00M | -2.88% | 153,847 | 60.70M |
| 492 | CV | CapsoVision, Inc. | 355.43M | 2.47% | 125,166 | 13.92M |
| 493 | AUNA | Auna S.A. | 353.41M | 3.13% | 194,754 | 1.37B |
| 494 | ASPE | Aspen Neuroscience, Inc. | 350.98M | -1.31% | 238,296 | - |
| 495 | EMBC | Embecta Corp. | 347.32M | -1.92% | 933,845 | 1.02B |
| 496 | STLN | Starling Oncology, Inc. | 346.26M | -4.10% | 4,010,680 | 620.45M |
| 497 | TLRY | Tilray Brands, Inc. | 345.39M | 0.64% | 3,890,460 | 963.10M |
| 498 | VMD | Viemed Healthcare, Inc. | 343.31M | -0.98% | 168,382 | 310.37M |
| 499 | PRLD | Prelude Therapeutics Incorporated | 342.83M | -2.64% | 422,305 | 21.57M |
| 500 | PROK | ProKidney Corp. | 335.64M | 6.73% | 1,135,814 | 775.00K |